Screening, Diagnosis and Treatment of Fabry Disease

Clinical pharmacology and therapy
doi 10.32756/0869-5490-2019-3-68-74
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pharmapress LLC

Related search

Time Delays in the Diagnosis and Treatment of Fabry Disease

International Journal of Clinical Practice
Medicine
2017English

Newborn Screening for Fabry Disease in Japan: Prevalence and Genotypes of Fabry Disease in a Pilot Study

Journal of Human Genetics
Genetics
2013English

High Incidence of Later-Onset Fabry Disease Revealed by Newborn Screening*

American Journal of Human Genetics
Genetics
2006English

Fabry Disease

Revista de la Facultad de Medicina Humana
2018English

Introduction to the Newborn Screening, Diagnosis, and Treatment for Pompe Disease Guidance Supplement

Pediatrics
Child HealthPediatricsPerinatology
2017English

Psy23 - Agalsidase Alfa and Agalsidase Beta for Treatment of Fabry Disease

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Fabry Disease

Archives of Dermatology
2004English

Screening for Fabry Disease in Patients With Chronic Kidney Disease: Limitations of Plasma -Galactosidase Assay as a Screening Test

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2007English

Early Diagnosis of Peripheral Nervous System Involvement in Fabry Disease and Treatment of Neuropathic Pain: The Report of an Expert Panel

BMC Neurology
MedicineNeurology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy